Skip to content

Organogenesis Holdings Inc. ORGO Current maturities of long-term debt

Current maturities of long-term debt at other companies

Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
Bioventus logo
BioventusBVS
Artivion logo
ArtivionAORT
Axogen logo
AxogenAXGN
Vericel logo
VericelVCEL
AngioDynamics logo
AngioDynamicsANGO

Other financials

Income statement

See full
Revenue$37.2M-57.1%
Gross profit$63.0M-22.5%
Operating income-$68.9M-158%
Net income-$53.2M-182%
EPS (diluted)-$0.44-159%

Balance sheet

See full
Cash & equivalents$91.4M-16.9%
Total debt$39.4M+24.8%
Total equity$244.6M+0.7%
Total assets$520.0M+11.3%

Cash flow

See full
Operating cash flow$21.1M+206%
CapEx$3.1M-13.2%
Free cash flow$18.0M+176%

Valuation

See full
Market cap$312.68M-23.7%
Enterprise value$260.72M-21.3%
P/E115×
P/S0.6×-0.3×

Profitability

See full
Gross margin75.9%+0.8pp
Operating margin0.5%
Net margin0.5%+0.3pp
FCF margin6.9%

Returns & leverage

See full
Return on equity1.1%+0.6pp
Debt / equity0.2×0.0×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Organogenesis Holdings Inc. in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.

The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s current maturities of long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s current maturities of long-term debt?
Organogenesis Holdings Inc. (ORGO) reported current maturities of long-term debt of $508K in Q1 2026.
How has Organogenesis Holdings Inc.'s current maturities of long-term debt changed year-over-year?
Organogenesis Holdings Inc.'s current maturities of long-term debt decreased by 57.4% year-over-year, from $1.19M to $508K.
What is the long-term trend for Organogenesis Holdings Inc.'s current maturities of long-term debt?
Over 4 years (2020 to 2025), Organogenesis Holdings Inc.'s current maturities of long-term debt has grown at a 27.1% compound annual growth rate (CAGR), from $3.62M to $9.44M.